JACQUELYN ADLEY: Open Payments
NPI 1487990230 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,633 in 146 payments from 26 companies in 2025. Trend: 2023 $2,622 · 2024 $3,031 · 2025 $2,633
Food & beverage: $2,633
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 25 | $452 |
| Madrigal Pharmaceuticals | 12 | $310 |
| Amgen Inc. | 18 | $299 |
| Xeris Pharmaceuticals, Inc. | 16 | $217 |
| RECORDATI_RARE_DISEASES_INC. | 12 | $215 |
| Novo Nordisk Inc | 13 | $173 |
| Mannkind Corporation | 8 | $146 |
| ABBVIE INC. | 5 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $87 |
| Novartis Pharmaceuticals Corporation | 4 | $64 |
Products named: MOUNJARO, REZDIFFRA, ISTURISA, REPATHA, AFREZZA, RECORLEV, JARDIANCE, TEPEZZA.
Industry payments across IN — which companies pay providers there.
